Opens in a new tab

Interview with Dr. Jotani, Intestinal Flora Transplantation Clinician, “Thoughts on the Establishment of the Study Group”

At Symbiosis Institute, we are mainly engaged in research and development of transplantation of intestinal bacteria (plexus) (intestinal flora transplantation) under the theme of “coexistence and co-prosperity with microorganisms”. The actual transplants are performed on patients by clinicians who belong to the “Intestinal Flora Transplantation Clinical Study Group. Today we bring you an interview with…

At Symbiosis Institute, we are mainly engaged in research and development of transplantation of intestinal bacteria (plexus) (intestinal flora transplantation) under the theme of “coexistence and co-prosperity with microorganisms”. The actual transplants are performed on patients by clinicians who belong to the “Intestinal Flora Transplantation Clinical Study Group. Today we bring you an interview with Dr. Masahiko Shirotani, Director of Luke’s Ashiya Clinic who is also the Executive Director of the Study Group, among the ” affiliated medical institutions where intestinal bacteria (plexus) transplants are available”! *What is referred to in the text as “Shimizu-style intestinal flora transplantation” is a transplantation using our method. (You can also watch the YouTube video at the bottom of this article.) Luke's Ashiya Clinic

How did we come to focus on intestinal flora?

At Luke’s Ashiya Clinic, we aim to treat the root cause of disease. We believe that it is very important to maintain a good intestinal environment in order to achieve the root cure. I originally started this clinic because I myself had an intestinal disease (ulcerative colitis) and learned firsthand the importance of regulating the intestinal environment. I heard that a university was doing a transplant of intestinal bacteria (plexus), and in fact I have experienced the transplant myself. Unfortunately, however, it was not as effective as I had hoped. As I continued my research, I heard that transplantation could be done in a more effective way, and I suddenly began to pay attention to the intestinal flora.

What is the difference between a transplant at a university hospital and a transplant at a university hospital?

First of all, the transplantation of intestinal bacteria (plexus) in the Shimizu method is a simple method of transplantation. I think it has an advantage because it reduces the burden on the patient. Also, my own experience is the physical changes after transplantation. When I had an intestinal bacteria (plexus) transplant at a university hospital, I did not feel any change in my body after the transplant. This time, when I received the Shimizu-style transplant myself, I did not understand it immediately at first, but after a few days, I could feel that my body was feeling very much better.

What is a transplant of intestinal bacteria (plexus) in the first place?

When I first heard about the concept of transplantation, I thought, “How outlandish is it to put human stool into the body?” But the more I thought about it, the more I investigated the role of intestinal flora, the more I began to think that it might be an effective method. In fact, I began to pay attention to it with high expectations, thinking that it may become an indispensable treatment method for the fundamental treatment that we are aiming for at our clinic.

What to expect from a gut microbiota (flora) transplant?

In fact, our hospital was also planning to transplant intestinal bacteria (plexus) by preparing various tools. However, the biggest obstacle was to find a donor for transplantation, and we gave up on the idea. Shimizu-style intestinal flora transplantation has already established a donor bank. I am hopeful that by utilizing the donor bank, this intestinal flora transplantation will dramatically benefit many patients.

Demonstration of the effectiveness of Shimizu-style intestinal flora transplantation

At the university, the basic transplantation technique is to use saline solution, but the Shimizu method uses a special bacterial solution, which has generated a lot of interest. From now on, I think it is very important for us to actually demonstrate the effectiveness of this method compared to the actual saline solution and to provide evidence. I know from personal experience that it is effective in transplanting intestinal bacteria (plexus), and I am confident that it will surely become a bacterial solution that attracts attention.

Future Activities as Executive Director of the Study Group

First of all, we would like many people to know that transplantation of intestinal bacteria (plexus) is an option. After that, we would be happy if we can help those who are suffering from intractable diseases that have not improved after trying various treatments. As a board member, I would like to focus on educational activities through this study group so that many people will become aware of the benefits of transplantation. For a transplant consultation at Luke’s Ashiya Clinic (Hyogo, Japan), please visit the Luke’s Ashiya Clinic website at

Related Articles

  • 城谷昌彦医師|IBS・潰瘍性大腸炎のQOLを変えるFMT治療の現在地

    日々の診療の中で、従来の標準治療だけでは十分に対応しきれない慢性的な消化器疾患。特に、潰瘍性大腸炎や過敏性腸症候群(IBS)を患う人々は、検査数値や画像所見だけでは見えにくい深い不安と、生活上の大きな制限を抱え続けている。 城谷バイオウェルネスクリニックの城谷昌彦医師が「腸内フローラ移植(FMT)」という新たな治療領域に関心を持った大きなきっかけ―――それは、他でもない先生自身が回腸嚢炎の治療法の一つとしてFMTを自ら受けた経験にあった。 自ら患者としてFMTを体験した医師は、臨床でNanoGAS®-FMT(水素ナノバブル水を用いた腸内フローラ移植)をどう活かし、患者の人生をどう変えているのか。そして、なぜ今、期待ばかりをあおることなく「慎重なエビデンスの検証」を訴え続けるのか。 「医療の成果は、単に症状や検査数値の改善だけではありません。患者さんが本来取り組みたかったことに再び向き合えるようになること、将来に前向きな気持ちを持てるようになることこそが、非常に大切な成果なのです。」 城谷医師の医療哲学と、2026年9月に開催される「第10回 一般財団法人腸内フローラ移植臨床 学術大会」に向けた見どころに迫る。 数値や画像には映らない「患者の不安」に向き合う 自らがFMTを受けた経験―――腸内細菌という「切り札」 「私自身、回腸嚢炎に対する治療法の一つであるFMTを大学の治験を通じて受けたことが、腸内フローラ移植に関心を持つ大きなきっかけでした」と、自らの患者体験と、消化器専門医としての深い葛藤を振り返る。 日々の診療において、従来の標準治療だけではどうしても対応しきれない患者の症状や経過に向き合うことは決して少なくない。中でも、潰瘍性大腸炎やIBS(過敏性腸症候群)の患者は、内視鏡検査や血液検査の数値だけでは測れない「いつお腹が痛くなるか分からない」「外出や外食が怖い」といった日常生活上の制限や精神的な不安を常時抱えている。 「腸内フローラを整えることは、単なる消化器症状の改善にとどまらず、患者さんのQOL(生活の質)を根本から向上させる可能性を秘めている」。自らの体験と臨床での実感から、腸内細菌へのアプローチを従来の治療を補完する「切り札」の一つとして見出すようになった。 NanoGAS®-FMTという新たな選択肢の可能性 大学の治験でFMTを受けたものの、大きな改善は見られなかったが、その可能性を感じることはできたという。数あるFMTの中でNanoGAS®-FMTを導入した理由は、「臨床現場での扱いやすさ」と「患者への負担軽減」にあったという。 従来の移植法と比較しても、患者への心身の負担に配慮しながら実施できる可能性を感じたことが大きな決定打となった。これまで既存の治療法を試しても十分な改善が得られなかった患者に対して、「腸内環境の再構築」という全く新しい選択肢を提示できるようになった意義は極めて大きい。 しかし、城谷医師は戒めを忘れない。 「一方で、FMTを『万能の治療法』のように扱うべきではないとも考えています。すべての患者さんに同じ結果が出るわけではありませんし、適応の見極め、既存治療との組み合わせ、そして治療前後の評価は極めて慎重に行う必要があります」 将来への不安を抱えた若い潰瘍性大腸炎患者の劇的な変化…

If you are concerned about your intestinal flora, start by consulting us.

Request FMT Treatment